News Focus
News Focus
icon url

LakeshoreLeo1953

10/23/22 11:30 AM

#379567 RE: Investor2014 #379565

"It is considered unethical to required patients to stop taking SOC when part of clinical trial of an unapproved drug"

Tough concept for some to accept.
icon url

georgejjl

10/23/22 12:26 PM

#379576 RE: Investor2014 #379565

Aricept contains the active drug donepezil, which is classified as an acetylcholinesterase inhibitor. It's used to treat dementia due to Alzheimer's disease. Aricept is not a psychotropic drug.



https://www.medicalnewstoday.com/articles/drugs-aricept#about

From the clinical trials.gov Phase 2b/3 details:

Prescription medication yielding a positive drug screen are acceptable except for tricyclic antidepressants (e.g. Amitriptyline, Amoxapine, Desipramine, (Norpramin) Doxepin, Imipramine (Tofranil), Nortriptyline (Pamelor), Protriptyline (Vivactil), Trimipramine (Surmontil)).

Donepezil (Aricept) is NOT an approved medicine for the Phase 2b/3 trial and it was removed as an approved medicine for the Phase 2a Blarcamesine trial.

GOD bless,
icon url

bas2020

10/23/22 7:57 PM

#379651 RE: Investor2014 #379565

It is considered unethical to required patients to stop taking SOC when part of clinical trial of an unapproved drug.


Too bad it's not considered unethical to require a placebo control arm for AD, PD, MS and ALS trials when there's ample evidence of placebo effect in a multitude of past trials. We can only hope that External Control Arms will soon be accepted for the same ethical reasons you state. I believe the FDA has recently adopted ECAs for oncology.
icon url

powerwalker

10/23/22 8:07 PM

#379656 RE: Investor2014 #379565

So, all those cancer drugs trials included the SOC as part of the prescriptions that the participants needed to take?

I still SMH that trials have to allow the SOC which might negate the benefits of the trial drug.